INS and metabolic disease: We hypothesized that nonpathogenic mtDNAs from a mouse less susceptible to metabolic diseases (e.g., C3H/HeN) could improve aspects of glucose metabolism, including glucose tolerance and insulin sensitivity, when placed on the same nuclear genetic background as a more susceptible mouse strain (C57BL/6J).